Budapest, Hungary

Lajos Szbao


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Lajos Szabo: Innovator in Pharmaceutical Chemistry**

Introduction

Lajos Szabo is a notable inventor based in Budapest, Hungary, known for his contributions to the field of pharmaceutical chemistry. His innovative work primarily focuses on new chemical compounds that may significantly benefit therapeutical applications.

Latest Patents

Lajos Szabo holds a patent for "Hexahydroindoloquinolizinium and octahydroindoloquinolizine esters." This invention pertains to novel hydroxyamino-eburnane derivatives characterized by a specific general formula. The compounds defined in this patent can function as peripheral vasodilating agents or serve as precursors to other pharmacologically valuable derivatives such as vincamine and apovincamine. His patented process involves complex chemical reactions, including catalytic hydrogenation and the use of nitrosating agents, demonstrating his expertise in synthetic organic chemistry.

Career Highlights

Szabo currently works with Richter Gedeon Vegyeszeti Gyar Rt, a prominent company in the pharmaceutical sector. His career reflects a strong dedication to advancing medicinal chemistry and enhancing therapeutic options available for various cardiovascular ailments.

Collaborations

Throughout his professional journey, Lajos Szabo has collaborated with esteemed colleagues including Csaba Szantay and Gyorgy Kalaus. Their collective efforts have been vital in driving innovation and translating research findings into practical pharmaceutical applications.

Conclusion

Lajos Szabo's contributions to pharmaceutical chemistry highlight the importance of innovation in the healthcare industry. His patent reflects not only his ingenuity but also the potential impact of his work on drug development and patient care. As ongoing research continues to evolve, Szabo's inventions may pave the way for groundbreaking treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…